Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Oncotarget|November 27, 2016
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Physics in Medicine and Biology|July 5, 2011
Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert studyM A Deeley, A Chen, R Datteri, et al.
Oncotarget|May 4, 2018
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2012
MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for gliomaJohn S Jarboe, Joshua C Anderson, Christine W Duarte, et al.
Molecular Cancer Therapeutics|November 17, 2017
JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of CholangiocarcinomaPatrick L Garcia, Aubrey L Miller, Tracy L Gamblin, et al.
Cancer Letters|May 4, 2024
BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabineAubrey L Miller, Samuel C Fehling, Rebecca B Vance, et al.
JCO Oncology Practice|January 11, 2023
An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical TrialsNadine J Barrett, Leigh Boehmer, Janelle Schrag, et al.
Molecular Cancer Research : MCR|March 11, 2018
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaRebecca C Arend, Angelina I Londoño, Allison M Montgomery, et al.
JCI Insight|July 19, 2022
An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinasesChristian T Stackhouse, Joshua C Anderson, Zongliang Yue, et al.
Therapeutic Advances in Medical Oncology|April 22, 2020
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancerDavid W Doo, Selene Meza-Perez, Angelina I Londoño, et al.
Pageof 13